These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 14709300)

  • 1. Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.
    Rho DS
    J Cataract Refract Surg; 2003 Dec; 29(12):2378-84. PubMed ID: 14709300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
    Heier JS; Topping TM; Baumann W; Dirks MS; Chern S
    Ophthalmology; 2000 Nov; 107(11):2034-8;discussion 2039. PubMed ID: 11054327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
    Wittpenn JR; Silverstein S; Heier J; Kenyon KR; Hunkeler JD; Earl M;
    Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.
    Asano S; Miyake K; Ota I; Sugita G; Kimura W; Sakka Y; Yabe N
    J Cataract Refract Surg; 2008 Jan; 34(1):57-63. PubMed ID: 18165082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, Randomized Study Comparing the Effect of 0.1% Nepafenac and 0.4% Ketorolac Tromethamine on Macular Thickness in Cataract Surgery Patients With Low Risk for Cystoid Macular Edema.
    Ramakrishnan S; Baskaran P; Talwar B; Venkatesh R
    Asia Pac J Ophthalmol (Phila); 2015; 4(4):216-20. PubMed ID: 26225780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP; Solomon KD; Sandoval HP; Vroman DT
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.
    Donnenfeld ED; Perry HD; Wittpenn JR; Solomon R; Nattis A; Chou T
    J Cataract Refract Surg; 2006 Sep; 32(9):1474-82. PubMed ID: 16931258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
    Flach AJ; Dolan BJ
    Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction.
    Weisz JM; Bressler NM; Bressler SB; Schachat AP
    Ophthalmology; 1999 Sep; 106(9):1656-9. PubMed ID: 10485530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intraocular ketorolac tromethamine for the treatment of chronic cystoid macular edema.
    Margalit E; Boysen JL; Zastrocky JP; Katz A
    Can J Ophthalmol; 2010 Aug; 45(4):409-10. PubMed ID: 20648080
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.
    Ticly FG; Lira RP; Zanetti FR; Machado MC; Rodrigues GB; Arieta CE
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):495-501. PubMed ID: 24735005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudophakic cystoid macular edema: ketorolac alone vs. ketorolac plus prednisolone.
    Singal N; Hopkins J
    Can J Ophthalmol; 2004 Apr; 39(3):245-50. PubMed ID: 15180141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of pseudophakic cystoid macular edema with combination therapy of topical corticosteroids and nonsteroidal anti-inflammatory drugs.
    Romac I; Gabrić N; Dekaris I; Barisić A
    Coll Antropol; 2011 Sep; 35 Suppl 2():281-4. PubMed ID: 22220453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery.
    Scuderi B; Driussi GB; Chizzolini M; Salvetat ML; Beltrame G
    Eur J Ophthalmol; 2003 Jul; 13(6):536-40. PubMed ID: 12948311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of topical diclofenac on choroidal blood flow in early postoperative pseudophakias with regard to cystoid macular edema formation.
    Miyake K; Nishimura K; Harino S; Ota I; Asano S; Kondo N; Miyake S
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5647-52. PubMed ID: 18055815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
    el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
    Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV; Westfield KC; Chalkley TH
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.